Acidul Piroglutamic performanta cognitiva stimulator cerebral|acetilcolina neurotransmitator
Acidul Piroglutamic
Acidul Piroglutamic creste capacitatea
de memorare
3.Acidul Piroglutamic un stimulator cerebral
cu efect la prevenirea
declinului cognitiv
si mentine nivelul ridicat in cerebral de acetilcolina un neurotransmitator
important
Acidul Piroglutamic un stimulator cerebral
cu efect la prevenirea declinului cognitiv
|
|
|
4. Acidul Piroglutamic un stimulator cerebral inbunatateste capacitatea de
memorare
| Neuron |
Neurotransmitatorii transmit influxul
nervos de la neuron spre neuriti (ramificati de dendrite si axon) |
 |
 |
| Sinapsa |
Exogeneza la nivelul celular |
 |
 |
| Acetilcolina ACh - Neurotransmitator |
Acetilcolinesteraza hidrolizeaza neurotransmitatorul acetilcolina
in acetat si colina |
 |
 |
Acetilcolina neurotransmitator creste efectul la nivelul sinapselor

5. Acidul Piroglutamic reduce amnezia si scaderea
nivelului
de acetilcolina un neurotransmiter important
6. Acidul Piroglutamic cu efect metabolic la circulatia in vasele
centrale
cerebrale.
7. Acidul Piroglutamic la circulatia cerebrala
8. Acidul Piroglutamic substanta cu proprietati farmacologice
agentului nootropic de origine endogena
9. Acidul Piroglutamic un agent nootropic, poate penetra bariera
hemato-encefalica, ca si L-Glutamina.
10. Acidul Piroglutamic cu efect la transmisia glutamatergica la
cortexul striat
11. Acidul Piroglutamic cu potential terapeutic la senilitate cognitiva
impiedica
declinul cognitiv
| Acidul Piroglutamic cu potential terapeutic la senilitate cognitiva |
 |
12. Acidul Piroglutamic sau L-Piroglutamat
aminoacid in trendul stiintei farmacologice
13. Sinteza, proprietati fizice si bio-disponibilitatea
Acidului Piroglutamic esteri ai Paracetamolului ca potentiali folositori
alternativi, cu efecte benefice
14. Arginin Piroglutamat sarea Acidului Piroglutamic
cu calitati de secretie a hormonului de crestere HGH la copii, studiu randomizat
dublu orb placebo controlat.
15. Acidul Piroglutamic cu eficienta
de virucid, in tratamentul
miinilor ca prevenire a rinitei virale.
16. Acidul Piroglutamic cu eficienta
de virucid, in tratamentul de desinfectie la rinita
virala
Terapia Anti Aging:
Anti-Aging-Systeme
- Formula
AntiAging
Bibliografie-Referinte
Acidul Piroglutamic

Informatii din bibliografia electronica la tema: Nutritie
si sanatate
1. Drago, F., Continella, G., Valerio, C., D’Agata, V., Astuto, C.,
Spardaro, F., Scapagnini, U. “Effects of Pyroglutamic Acid on Learning
and Memory Processes of the Rat.” Acta Therapeutica. 1987, Vol. 13, pp.
587-94.
2. Drago F, Valerio C, D'Agata V, et al. Pyroglutamic acid improves learning
and memory capacities in old rats. Funct Neurol. 1988; 3:137-143.
3. Grioli, S. et al. “Pyroglutamic Acid Improves the Age Associated Memory
Impairment.” Fundamental and Clinical Pharmacology. 1990, Vol. 4, pp.
169-73.
4. Spignoli G, Magnani M, Giovannini MG, Pepeu G. Effect of pyroglutamic acid
stereoisomers on ECS and scopalamine-induced memory disruption and brain acetylcholine
levels in the rat. Pharmacol Res Commun. 1987; 19:901-912.
5. Spignoli, G., Magnani, M. Pepeu, G. “Pyroglutamic Acid Antagonizes
the Amnesic Effect and the Decrease in Brain Acetylcholine Level Induced by
Scopolamine.” Pharmacological Research Communications. 1987, Vol. 10,
pp. 901-7.
6. Mirzoian SA, Zalinian MG, Balasanian MG, Topchian AV. The central vascular
and metabolic effects of pyroglutamic acid. Eksp Klin Farmakol. 1994 Jan-Feb;57(1):22-4.
7. Eksp Klin Farmakol 2002 May-Jun; 65(3):3-5 Effect of a drug composition
containing pyroglutamic acid and pyrrolidone on the cerebral circulation
8. J Drug Dev 1988 1 157-62 Pharmacological Properties of a Nootropic Agent
of Endogenous Origin: D-Pyroglutamate. Fundamental and Clinical Pharmacology
1990 Vol 4 pp 169-73
9. Barone D, Spignal G. Investigations on the binding properties of the nootropic
agent pyroglutamic acid. Drugs Exp Clin Res. 1990; 16:85-99.
10. Dusticier N., Kerkerian L., Errami M., Nieoullon A. Effects of pyroglutamic
acid on corticostriatal glutamatergic transmission. Neuropharmacology 1985;24:903-908
11. Moos WH, Hershenson FM. Potential therapeutic strategies for senile cognitive
disorders. Drug News Perspect. 1989; 2:397-409.
12. Moret, C., Briley, M. “The Forgotten Amino Acid Pyroglutamate.” Trends
in Pharmacological Sciences. 1988, Vol. 9, pp. 278-9.
13. Bousquet E, Marrazzo A, Puglisi G, Spadaro A, Tirendi S.Synthesis, physical
properties, toxicological studies and bioavailability of L-pyroglutamic and
L-glutamic acid esters of paracetamol as potentially useful prodrugs. Istituto
di Chimica Farmaceutica e Tossicologica, Universita di Catania, Italy. J Pharm
Pharmacol. 1996 May;48(5):479-85.
14. Filippo, V., Spignoli, G., Isidori, A. “Effects of Arginine Pyroglutamate
on Growth Hormone in Children.” Clinical Trials Journal. 1987, Vol. 24,
pp. 387-90.
15. Turner RB, Hendley JO. Virucidal hand treatments for prevention of rhinovirus
infection. Department of Pediatrics, U |